Skin Sensitisation Tests

Gentronix provides in chemico and in vitro services for investigating key events of the skin sensitisation adverse outcome pathway (AOP). Using this battery of assays enables weight-of-evidence approaches to be adopted for the hazard assessment of potential skin sensitisers without using laboratory animals. Our team of experts can help you deliver the correct combination of these assays for your project, along with the interpretation of the results with regard to the AOP. Through our comprehensive services, we ensure accurate identification and assessment of skin sensitisation potential, helping you meet safety and regulatory requirements efficiently.